On July 8, 2022 Simbec-Orion reported that We are excited to be attending the World Orphan Drug Congress USA in Boston (Press release, Simbec-Orion, JUL 8, 2022, View Source [SID1234616564])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.

Driving complex rare and orphan clinical development programs forward on a successful path has been our focus for more than 25 years, and we would love to learn more about your needs. Connect with Romillie Cruz, MD and Maria Frane during the meeting at booth 636, or by scheduling your meeting today https://bit.ly/3O3vfXb #raredisease #WorldOrphanUSA